ACTIVE SESSION TAPE Biotechnology $26M Cap Quant: HOLD

Why Is CASI Pharmaceuticals, Inc. (CASI) Stock Down Today?

Updated Nov 22, 2026 5:31 AM ET ยท Prev Close $0.80

Pro Workspace
Last Session Price
$0.21 -74.06%
-$0.59 vs $0.80 prior close
Intraday Range
$0.21 โ€“ $0.37
Open $0.34
Relative Volume
1.00x Avg
6,838,433 sh
52-Week Range
$0.21 โ€“ $0.37
Benchmark Alpha
-70.42% vs SPY
-68.39% vs QQQ
20-Session Trend
Click Interactive Chart for full OHLCV history

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

CASI Pharmaceuticals, Inc. Pulling Back 74.06% on 1.00x Relative Volume

CASI Pharmaceuticals, Inc. (CASI) is pulling back 74.06% (-$0.59) to $0.21 on 1.00x average session volume. Relative to benchmarks, CASI is lagging the S&P 500 by -70.42%. 14-day RSI stands at 18.4, keeping momentum in a oversold regime.

NEWS 70% Weight
CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel

South San Francisco, Ca Access Newswire February 25, 2026 CASI Pharmaceuticals, Inc. Nasdaq Casi , a clinical-stage biopharmaceutical company focused on developing Cid-103, a potential best-in-class, anti-CD38 monoclonal

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($0.21) trades relative to 20-day SMA ($0.84) and 50-day SMA ($0.88).

Volume Confirmation
MODERATE VOLUME (1.00x) Normal
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

CASI lagging the S&P 500 by -70.42%
CASI Session
-74.06%
$0.21
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: -70.42% Alpha vs QQQ: -68.39% Alpha vs XLV: -73.94%

Options Flow & Execution Desk

Recent CASI Catalyst Headlines

Verified Wire

1โ€“3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$0.20
Short-term support band
Upper Bound
$0.22
Short-term resistance band
Key Inflection Level
$0.21 (session support)

Monitor volume expansion above 1.5x RVOL around $0.21 (session support) for directional breakout confirmation.

Technical Regime (CASI)

BEARISH MA TREND
RSI (14)
18.4
Oversold
20-Day SMA
$0.84
Below 20d
50-Day SMA
$0.88
Below 50d
MACD Signal
Bearish
MACD -0.10
ADX (14)
18.4
Weak trend
10d Momentum
-0.60
Soft 10-day momentum

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

CASI Pharmaceuticals announced it will be delisted from Nasdaq due to failure to meet listing requirements. The Company intends to trade on the OTC market following delisting.

Reddit communities: 1 comment (Neutral)

About CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The Evomela injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include Cid-103, CNCT19, Evomela, Marqibo, โ€ฆ

Sector
Healthcare
Market Cap
$26M
Employees
233

Get Instant CASI Catalyst Alerts

Receive an email alert when CASI triggers an unusual volume breakout, options sweep, or rating shift.

CASI Session & Catalyst FAQ

Why is CASI stock down today?

CASI Pharmaceuticals, Inc. (CASI) is pulling back 74.06% (-$0.59) to $0.21 on 1.00x average session volume. Relative to benchmarks, CASI is lagging the S&P 500 by -70.42%. 14-day RSI stands at 18.4, keeping momentum in a oversold regime.

Is CASI stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 1.00x relative volume (moderate participation). Our multi-factor model currently rates CASI as HOLD. Review full valuation, quality, and timing signals on the CASI Buy or Sell Decision Brief โ†’

What is CASI's intrinsic value and expected trading range?

At $0.21, CASI's modeled 1-to-3 session range is $0.20 โ€“ $0.22, with a key inflection level at $0.21 (session support). Compare current price against multi-year cash flow projections in the CASI Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for CASI?

RSI at 18.4 indicates oversold conditions โ€” watch for mean-reversion support. CASI trades at $0.21 relative to its 20-day SMA ($0.84) and 50-day SMA ($0.88), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs